131 results
Interferon lambda is a promising new outpatient therapy for COVID-19, but will it get the chance to ‘interfere’ with the pandemic?
Explore a clinical case of a patient suffering from Long COVID-19 syndrome and learn how members of their interprofessional care team, mainly physical and occupational therapists, can support their recovery.
Here are five important points about antibody testing for diagnosis of COVID-19 from the EBM Focus team at DynaMed.
DynaMed® Clinical Editor Dr. Katharine DeGeorge separates fact from fiction when it comes to measures to prevent SARS-CoV-2 transmission.
Remdesivir reduces duration of illness in patients with severe COVID-19, but what about patients with moderate disease? Read this EBM Focus article to learn more.
Is remdesivir the miracle drug we need for COVID-19? Read DynaMed’s EBM Focus to find out.
The EBM Focus team at DynaMed® discusses a large cohort study evaluating risk of myocarditis after COVID vaccination.
Pharmokinetic profiles guide drug dosing regimens, but how are vaccine dosing regimens determined? DynaMed® editors break down this difference and illustrate the influence of age, especially as the COVID-19 vaccines roll out.
A new meta-analysis establishes some efficacy for corticosteroids for COVID-19, but with several limitations. Read more in this EBM Focus article.
As countries and regions debate about deploying COVID vaccine booster shots, DynaMed® offers responses to common questions.